MD Pediatrix Medical Group Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$31.435

Market cap

$2.46B

P/E Ratio

16.63

Dividend/share

N/A

EPS

$1.89

Enterprise value

$2.76B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 58

Pediatrix® Medical Group, Inc. is the nation’s leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across ...

Highlights
The debt has decreased by 4.7% YoY
Pediatrix Medical Group's gross profit has increased by 3.1% YoY
The P/E is 43% above the last 4 quarters average of 11.6
The quick ratio has declined by 31% year-on-year and by 2.4% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.mednax.com
Peers: THC UHS CYH

Key stats

What are the main financial stats of MD

MD stock price

How has the Pediatrix Medical Group stock price performed over time
Intraday
-0.05%
1 week
-1.27%
1 month
16.77%
1 year
38.54%
YTD
46.96%
QTD
22.17%

Financial performance

How have Pediatrix Medical Group's revenue and profit performed over time
Revenue
$1.96B
Gross profit
$511.69M
Operating income
$212.58M
Net income
$150.09M
Gross margin
26.1%
Net margin
7.7%
The net margin has decreased by 14% from the previous quarter and by 8% YoY
The net income has declined by 14% since the previous quarter and by 7% year-on-year
MD's operating income is up by 7% year-on-year
The operating margin has increased by 6% year-on-year

Price vs fundamentals

How does MD's price correlate with its fundamentals

Growth

What is Pediatrix Medical Group's growth rate over time

Valuation

What is Pediatrix Medical Group stock price valuation
MD P/E details
P/E
16.63
P/B
3.01
P/S
1.24
EV/EBIT
11.64
EV/EBITDA
10.58
EV/Sales
1.41
The P/E is 43% above the last 4 quarters average of 11.6
The company's EPS fell by 11% QoQ and by 2.1% YoY
The P/B is 77% above the 5-year quarterly average of 1.7 and 37% above the last 4 quarters average of 2.2
The equity is down by 4.6% YoY and by 3.6% QoQ
The stock's price to sales (P/S) is 77% more than its 5-year quarterly average of 0.7 and 24% more than its last 4 quarters average of 1.0

Efficiency

How efficient is Pediatrix Medical Group business performance
The ROIC is up by 28% YoY but it is down by 2.1% from the previous quarter
The ROA has contracted by 14% from the previous quarter and by 9% YoY
MD's return on equity is down by 13% since the previous quarter and by 13% year-on-year
The company's return on sales fell by 9% QoQ and by 3.2% YoY

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Pediatrix Medical Group financials performed over time
The total assets is 66% greater than the total liabilities
The quick ratio has declined by 31% year-on-year and by 2.4% since the previous quarter
The company's current ratio fell by 30% YoY and by 3% QoQ
The debt is 28% less than the equity
The debt has decreased by 4.7% YoY
The equity is down by 4.6% YoY and by 3.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.